Avid Bioservices, Inc. PPHM
No live quote for PPHM yet.
- Market cap
- 190.80M
- Revenue (ttm)
- 68.51M
- Profit margin
- -39.23%
- EPS (ttm)
- -0.747
- Shares out
- 45.21M
- Forward P/E
- -60.29
- Volume
- 93.09K
- Avg volume
- 264.34K
- Open
- 4.24
- Previous close
- 4.19
- Beta
- 3.10
- Analysts
- Buy
- Price target
- 10.00
Key statistics
- Enterprise value
- 144.53M
- PEG ratio
- 0.00
- Price / sales
- 2.78
- Price / book
- 4.44
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -45.30%
- Free cash flow
- -34.47M
- Total cash
- 27.73M
- Total debt
- 0
- Return on equity
- -63.17%
- Short % of float
- 1.50%
- 50-day average
- 4.22
- 200-day average
- 3.93
Analyst view
Consensus: buy
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.14.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 25, 2016 | Roth Capital | down | — | Neutral |
| Feb 25, 2016 | Roth Capital | down | — | Neutral |
| Mar 4, 2013 | PiperJaffray | init | — | Overweight |
| Jan 6, 2013 | Roth Capital | up | — | Buy |
| Sep 23, 2012 | Roth Capital | down | — | Neutral |
| Apr 12, 2012 | LifeTech Capital | down | — | Neutral |
About Avid Bioservices, Inc.
Avid Bioservices, Inc. operates as a contract development and manufacturing organization focusing on the development and cGMP manufacture of biopharmaceutical products derived from mammalian cell culture. It provides a range of process development, and cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The company produces monoclonal antibodies and recombinant proteins in batch, fed-batch, and perfusion modes; and provides services, including cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing, and regulatory strategy, submission, and support. It also offers various process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development, and product characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. is based in Tustin, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- avidbio.com
News
Your note
Sign in to keep a note on PPHM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAMFORTH MARK R | Director | Purchase | Oct 26, 2017 | 50,000 |
| KING STEVEN W | Officer | Acquisition (Non Open Market) | Oct 30, 2017 | 34,646 |
| SHAN JOSEPH | Officer | Acquisition (Non Open Market) | Oct 30, 2017 | 16,187 |